Verrucosin

CAS No. 83198-63-4

Verrucosin( ——— )

Catalog No. M39040 CAS No. 83198-63-4

Verrucosin (Compound 3) is a compound isolated from Myristica fragrans.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Verrucosin
  • Note
    Research use only, not for human use.
  • Brief Description
    Verrucosin (Compound 3) is a compound isolated from Myristica fragrans.
  • Description
    Verrucosin (Compound 3) is a compound isolated from Myristica fragrans.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    83198-63-4
  • Formula Weight
    344.4
  • Molecular Formula
    C20H24O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 50 mg/mL (145.18 mM; ultraphonic; )
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Nguyen PH, et al. AMP-activated protein kinase (AMPK) activators from Myristica fragrans (nutmeg) and their anti-obesity effect. Bioorg Med Chem Lett. 2010;20(14):4128-4131.?
molnova catalog
related products
  • Yuanhuacine

    Yuanhuacine (Gnidilatidin), a diterpene from Daphne genkwa, is an effective and highly selective inhibitor of the basal-like 2 (BL2) subtype of TNBC. Yuanhuacine can induce G2/M cell cycle arrest and has broad anti-tumor activity. Yuanhuacine is an orally active DNA damaging agent.

  • 20-Hydroxylucidenic ...

    20-Hydroxylucidenic acid E2 is a triterpenoid compound found in Ganoderma lucidum. It exhibits significant inhibitory effects on inflammation induced by TPA . Additionally, 20-Hydroxylucidenic acid E2 can suppress the expression of EBV early antigen induced by TPA , with a IC50 of 290 mol ratio/32 pmol TPA (meaning that when the molar concentration of this compound is 290 times that of 32 pmol of TPA, it can inhibit 50% of EBV early antigen expression). Therefore, 20-Hydroxylucidenic acid E2 has potential applications in anti-inflammatory and anticancer research.

  • (Z)-docos-13-en-1-ol

    (Z)-docos-13-en-1-ol (Erucyl alcohol) is found in jojoba oil.